1 report

  • Deal Report: Akonni Biosystems receives $3.2 million phase II small business innovation research grant from National Institutes of Health

Under the agreement, Akonni plans to develop products that expand its market presence beyond tests that detect infectious diseases like MRSA, MDR-TB or antiviral-resistant influenza.

  • Molecular Diagnostics
  • United States
  • Company
  • Corporate Finance
  • Akonni Biosystems, Inc.